Other

Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two

Caterpillar Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two decreased by 16.7% to $5.00M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two shows a downward trend with a -8.7% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2023
Last reportedQ4 2025
Metric ID: other_prescription_drug_subsidy_receipts_year_two1

Historical Data

3 periods
 Q4 '23Q4 '24Q4 '25
Value$6.00M$6.00M$5.00M
QoQ Change—+0.0%-16.7%
YoY Change—+0.0%-16.7%
Range$5.00M – $6.00M
Avg YoY Growth-8.3%
Median YoY Growth-8.3%

Frequently Asked Questions

What is Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year two?
Caterpillar (CAT) reported defined benefit plan, expected future prescription drug subsidy receipt, year two of $5.00M in Q4 2025.
What is the long-term trend for Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year two?
Over 2 years (2023 to 2025), Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year two has grown at a -8.7% compound annual growth rate (CAGR), from $6.00M to $5.00M.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.